Following the meltdown at Three Mile Island nuclear plant in 1979, ANBEX developed iOSAT for protection from an accidental or terrorist related release of radioactive iodine from a nuclear power plant or nuclear weapon.
iOSAT received its approval from the US Food and Drug Administration in 1982, and is the only full-strength tablet for radiation blocking which may legally be sold in the US.
Only iOSAT has passed all FDA tests for purity, quality, safety and efficacy.
Each standard package of IOSAT contains a strip of 14 tablets, with each tablet containing 130 mg of potassium iodide.
The tablets are double scored to split easily and cleanly into 65 mg and 32.5 mg child doses.
All IOSAT is fully FDA approved for thyroid blocking in a radiation emergency.